✦ LIBER ✦

Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina

✍ Scribed by María L. Cuestas; Cintia W. Rivero; María L. Minassian; Amalia I. Castillo; Emiliano A. Gentile; Julieta Trinks; Liliana León; Graciela Daleoso; Bernardo Frider; Carol Lezama; Marcela Galoppo; Gisela Giacove; Verónica L. Mathet; José R. Oubiña

Book ID: 113458387
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 158 KB
Volume: 87
Category: Article
ISSN: 0166-3542
DOI: 10.1016/j.antiviral.2010.04.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy of entecavir therapy

Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir

✍ M. S. Kwak; J. W. Choi; J. S. Lee; K. A. Kim; J. H. Suh; Y. S. Cho; S. Y. Won; B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

510 Viral resistance to adefovir therapy

510 Viral resistance to adefovir therapy results from reappeared wild type hepatitis B virus in majority of patients with YMDD mutants

✍ S.H. Ryu; Y.-H. Chung; J.A. Kim; M.H. Choi; Y.-S. Lee; S.W. Jung; D.D. Suh; H.J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

(160) Predictors of responses to adefovi

(160) Predictors of responses to adefovir therapy in patients with lamivudine-resistant hepatitis B virus YMDD mutant before and after liver transplantation

✍ Ahmed Helmy; Ayman. Abdo; Hatim Mudawi; Khalid Al-Kahtani; Hamad Al-Ashgar; Moha 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 41 KB